TreeWAS – Variant ID: rs9483788

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified	0.062	0.938	0.000
Z50.1 Other physical therapy	0.039	0.961	0.000
Z50 Care involving use of rehabilitation procedures	0.036	0.964	0.000
Z50.3 Drug rehabilitation	0.030	0.970	0.000
Z50.8 Care involving use of rehabilitation procedures	0.027	0.973	0.000
Z50.6 Orthoptic training	0.026	0.974	0.000
Z50.5 Speech therapy	0.025	0.975	0.000
Z50.2 Alcohol rehabilitation	0.025	0.975	0.000
Z50.4 Psychotherapy, not elsewhere classified	0.018	0.982	0.000
N73.9 Female pelvic inflammatory disease, unspecified	0.013	0.987	0.000
M24.16 Other articular cartilage disorders (Lower leg)	0.000	0.990	0.010
M24.15 Other articular cartilage disorders (Pelvic region and thigh)	0.000	0.990	0.010
M24.1 Other articular cartilage disorders	0.000	0.991	0.009
M24.41 Recurrent dislocation and subluxation of joint (Shoulder region)	0.000	0.992	0.008
Z50.9 Care involving use of rehabilitation procedure, unspecified	0.007	0.993	0.000
M24.13 Other articular cartilage disorders (Forearm)	0.000	0.993	0.007
M24.11 Other articular cartilage disorders (Shoulder region)	0.000	0.993	0.007
D63.0 Anaemia in neoplastic disease	0.007	0.993	0.000
Q61.3 Polycystic kidney, unspecified	0.000	0.993	0.007
O69.8 Labour and delivery complicated by other cord complications	0.007	0.993	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.007	0.993	0.000
M24.19 Other articular cartilage disorders (Site unspecified)	0.000	0.993	0.007
M24.18 Other articular cartilage disorders (Other)	0.000	0.993	0.007
M24.14 Other articular cartilage disorders (Hand)	0.000	0.993	0.007
M24.12 Other articular cartilage disorders (Upper arm)	0.000	0.993	0.007
M24.10 Other articular cartilage disorders (Multiple sites)	0.000	0.993	0.007
Y52.4 Angiotensin-converting-enzyme inhibitors	0.007	0.993	0.000
M24.17 Other articular cartilage disorders (Ankle and foot)	0.000	0.993	0.007
Y52 Agents primarily affecting the cardiovascular system	0.007	0.993	0.000
M24.4 Recurrent dislocation and subluxation of joint	0.000	0.993	0.007
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.007	0.993	0.000
Q61 Cystic kidney disease	0.000	0.993	0.007
O69.1 Labour and delivery complicated by cord around neck, with compression	0.007	0.993	0.000
Q61.2 Polycystic kidney, adult type	0.000	0.994	0.006
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.006	0.994	0.000
M24.47 Recurrent dislocation and subluxation of joint (Ankle and foot)	0.000	0.994	0.006
Q61.9 Cystic kidney disease, unspecified	0.000	0.994	0.006
O69 Labour and delivery complicated by umbilical cord complications	0.006	0.994	0.000
Q61.0 Congenital single renal cyst	0.000	0.994	0.005
Y52.7 Peripheral vasodilators	0.005	0.995	0.000
F40.2 Specific (isolated) phobias	0.005	0.995	0.000
M24.44 Recurrent dislocation and subluxation of joint (Hand)	0.000	0.995	0.005
Q61.5 Medullary cystic kidney	0.000	0.995	0.005
Y45.0 Opioids and related analgesics	0.005	0.995	0.000
H17.9 Corneal scar and opacity, unspecified	0.005	0.995	0.000
T18.1 Foreign body in oesophagus	0.005	0.995	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.005	0.995	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.005	0.995	0.000
M24.49 Recurrent dislocation and subluxation of joint (Site unspecified)	0.000	0.995	0.005
M24.48 Recurrent dislocation and subluxation of joint (Other)	0.000	0.995	0.005
M24.46 Recurrent dislocation and subluxation of joint (Lower leg)	0.000	0.995	0.005
M24.43 Recurrent dislocation and subluxation of joint (Forearm)	0.000	0.995	0.005
M24.42 Recurrent dislocation and subluxation of joint (Upper arm)	0.000	0.995	0.005
M24.40 Recurrent dislocation and subluxation of joint (Multiple sites)	0.000	0.995	0.005
Q61.8 Other cystic kidney diseases	0.000	0.995	0.005
Q61.4 Renal dysplasia	0.000	0.995	0.005
Q61.1 Polycystic kidney, infantile type	0.000	0.995	0.005
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.005	0.995	0.000
Y52.1 Calcium-channel blockers	0.005	0.995	0.000
D63 Anaemia in chronic diseases classified elsewhere	0.005	0.995	0.000
M24.45 Recurrent dislocation and subluxation of joint (Pelvic region and thigh)	0.000	0.995	0.005
O69.2 Labour and delivery complicated by other cord entanglement	0.004	0.996	0.000
O69.5 Labour and delivery complicated by vascular lesion of cord	0.004	0.996	0.000
O69.4 Labour and delivery complicated by vasa praevia	0.004	0.996	0.000
O69.3 Labour and delivery complicated by short cord	0.004	0.996	0.000
Z50.0 Cardiac rehabilitation	0.004	0.996	0.000
H17 Corneal scars and opacities	0.004	0.996	0.000
O69.9 Labour and delivery complicated by cord complication, unspecified	0.004	0.996	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
M24 Other specific joint derangements	0.000	0.996	0.004
K35.0 Acute appendicitis with generalised peritonitis	0.004	0.996	0.000
D61.9 Aplastic anaemia, unspecified	0.004	0.996	0.000
O69.0 Labour and delivery complicated by prolapse of cord	0.004	0.996	0.000
H17.8 Other corneal scars and opacities	0.004	0.996	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.004	0.996	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.004	0.996	0.000
D63.8 Anaemia in other chronic diseases classified elsewhere	0.004	0.996	0.000
D63.1 Anaemia in other chronic diseases classified elsewhere	0.004	0.996	0.000
O42.0 Premature rupture of membranes, onset of labour within 24 hours	0.000	0.996	0.004
Z45.0 Adjustment and management of cardiac pacemaker	0.000	0.996	0.004
Y41 Other systemic anti-infectives and antiparasitics	0.004	0.996	0.000
R04.0 Epistaxis	0.000	0.996	0.004
H00.1 Chalazion	0.000	0.996	0.004
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.003	0.996	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.996	0.000
Y49.2 Other and unspecified antidepressants	0.003	0.996	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.003	0.996	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.003	0.996	0.000
H18 Other disorders of cornea	0.003	0.997	0.000
D86.8 Sarcoidosis of other and combined sites	0.003	0.997	0.000
D61 Other aplastic anaemias	0.003	0.997	0.000
H17.1 Other central corneal opacity	0.003	0.997	0.000
H17.0 Adherent leukoma	0.003	0.997	0.000
G40.9 Epilepsy, unspecified	0.000	0.997	0.003
Y45.4 Antirheumatics	0.003	0.997	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.997	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.997	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.003	0.997	0.000
Y51.0 Anticholinesterase agents	0.003	0.997	0.000
M24.9 Joint derangement, unspecified	0.000	0.997	0.003
H18.8 Other specified disorders of cornea	0.003	0.997	0.000
M24.7 Protrusio acetabuli	0.000	0.997	0.003
N99.3 Prolapse of vaginal vault after hysterectomy	0.003	0.997	0.000
Y45.1 Salicylates	0.003	0.997	0.000
M24.6 Ankylosis of joint	0.000	0.997	0.003
H18.3 Changes in corneal membranes	0.003	0.997	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y58 Bacterial vaccines	0.003	0.997	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
L85.8 Other specified epidermal thickening	0.000	0.997	0.003
N73 Other female pelvic inflammatory diseases	0.003	0.997	0.000
H18.2 Other corneal oedema	0.003	0.997	0.000
T91.8 Sequelae of other specified injuries of neck and trunk	0.003	0.997	0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.003	0.997	0.000
Y49.9 Psychotropic drug, unspecified	0.003	0.997	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Y49.7 Psychostimulants with abuse potential	0.003	0.997	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.003	0.997	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
D86 Sarcoidosis	0.003	0.997	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.003	0.997	0.000
M24.3 Pathological dislocation and subluxation of joint, not elsewhere classified	0.000	0.997	0.003
Y53.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
Y48 Anaesthetics and therapeutic gases	0.003	0.997	0.000
D86.3 Sarcoidosis of skin	0.003	0.997	0.000
Y45.2 Propionic acid derivatives	0.003	0.997	0.000
Y49.5 Other antipsychotics and neuroleptics	0.003	0.997	0.000
H18.6 Keratoconus	0.003	0.997	0.000
Y41.5 Antiviral drugs	0.003	0.997	0.000
D60-D64 Aplastic and other anaemias	0.003	0.997	0.000
H18.9 Disorder of cornea, unspecified	0.003	0.997	0.000
Y41.0 Sulphonamides	0.003	0.997	0.000
H18.0 Corneal pigmentations and deposits	0.003	0.997	0.000
Y45.8 Other analgesics and antipyretics	0.003	0.997	0.000
H18.1 Bullous keratopathy	0.003	0.997	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
Y41.4 Anthelminthics	0.003	0.997	0.000
Y41.3 Other antiprotozoal drugs	0.003	0.997	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
Y41.1 Antimycobacterial drugs	0.003	0.997	0.000
S91.3 Open wound of other parts of foot	0.000	0.997	0.003
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
M23.32 Other meniscus derangements (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.000	0.997	0.003
D86.9 Sarcoidosis, unspecified	0.003	0.997	0.000
N73.5 Female pelvic peritonitis, unspecified	0.003	0.997	0.000
Z57.5 Occupational exposure to toxic agents in other industries	0.003	0.997	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.997	0.000
M24.2 Disorder of ligament	0.000	0.997	0.003
R90.8 Other abnormal findings on diagnostic imaging of central nervous system	0.000	0.997	0.003
Y48.4 Anaesthetic, unspecified	0.003	0.997	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.003	0.997	0.000
H18.7 Other corneal deformities	0.003	0.997	0.000
M21.37 Wrist or foot drop (acquired) (Ankle and foot)	0.000	0.997	0.003
H61.2 Impacted cerumen	0.000	0.997	0.003
Y47.1 Benzodiazepines	0.003	0.997	0.000
Y58.0 BCG vaccine	0.003	0.997	0.000
Y44 Agents primarily affecting blood constituents	0.003	0.997	0.000
D61.8 Other specified aplastic anaemias	0.003	0.997	0.000
D61.3 Idiopathic aplastic anaemia	0.003	0.997	0.000
D61.2 Aplastic anaemia due to other external agents	0.003	0.997	0.000
D61.0 Constitutional aplastic anaemia	0.003	0.997	0.000
H16 Keratitis	0.003	0.997	0.000
Y59 Other and unspecified vaccines and biological substances	0.003	0.997	0.000
M24.66 Ankylosis of joint (Lower leg)	0.000	0.997	0.003
D61.1 Drug-induced aplastic anaemia	0.003	0.997	0.000
H15 Disorders of sclera	0.003	0.997	0.000
M24.99 Joint derangement, unspecified (Site unspecified)	0.000	0.997	0.002
M24.98 Joint derangement, unspecified (Other)	0.000	0.997	0.002
M24.97 Joint derangement, unspecified (Ankle and foot)	0.000	0.997	0.002
M24.96 Joint derangement, unspecified (Lower leg)	0.000	0.997	0.002
M24.95 Joint derangement, unspecified (Pelvic region and thigh)	0.000	0.997	0.002
M24.94 Joint derangement, unspecified (Hand)	0.000	0.997	0.002
M24.93 Joint derangement, unspecified (Forearm)	0.000	0.997	0.002
M24.92 Joint derangement, unspecified (Upper arm)	0.000	0.997	0.002
M24.91 Joint derangement, unspecified (Shoulder region)	0.000	0.997	0.002
M24.90 Joint derangement, unspecified (Multiple sites)	0.000	0.997	0.002
S91.1 Open wound of toe(s) without damage to nail	0.000	0.997	0.003
Y45.5 4-Aminophenol derivatives	0.003	0.997	0.000
S91 Open wound of ankle and foot	0.000	0.997	0.003
M24.79 Protrusio acetabuli-Site unspec	0.000	0.997	0.002
M24.78 Protrusio acetabuli-Other	0.000	0.997	0.002
M24.77 Protrusio acetabuli-Ankle/foot	0.000	0.997	0.002
M24.76 Protrusio acetabuli-Lower leg	0.000	0.997	0.002
M24.74 Protrusio acetabuli-Hand	0.000	0.997	0.002
M24.73 Protrusio acetabuli-Forearm	0.000	0.997	0.002
M24.72 Protrusio acetabuli-Upper arm	0.000	0.997	0.002
M24.71 Protrusio acetabuli-Shldr region	0.000	0.997	0.002
M24.70 Protrusio acetabuli-Mult sites	0.000	0.997	0.002
M24.69 Ankylosis of joint (Site unspecified)	0.000	0.997	0.002
M24.68 Ankylosis of joint (Other)	0.000	0.997	0.002
M24.65 Ankylosis of joint (Pelvic region and thigh)	0.000	0.997	0.002
M24.64 Ankylosis of joint (Hand)	0.000	0.997	0.002
M24.63 Ankylosis of joint (Forearm)	0.000	0.997	0.002
M24.62 Ankylosis of joint (Upper arm)	0.000	0.997	0.002
M24.61 Ankylosis of joint (Shoulder region)	0.000	0.997	0.002
M24.60 Ankylosis of joint (Multiple sites)	0.000	0.997	0.002
H16.0 Corneal ulcer	0.003	0.997	0.000
Y40 Systemic antibiotics	0.003	0.997	0.000
N73.0 Acute parametritis and pelvic cellulitis	0.003	0.997	0.000
N85.8 Other specified noninflammatory disorders of uterus	0.000	0.997	0.003
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.997	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.997	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.997	0.000
Y53.7 Emetics	0.002	0.997	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.997	0.000
Y53.5 Digestants	0.002	0.997	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.997	0.000
Y53.2 Stimulant laxatives	0.002	0.997	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.997	0.000
M24.75 Protrusio acetabuli-Pelvic/thigh	0.000	0.997	0.002
N73.4 Female chronic pelvic peritonitis	0.002	0.997	0.000
N73.3 Female acute pelvic peritonitis	0.002	0.997	0.000
N73.2 Unspecified parametritis and pelvic cellulitis	0.002	0.997	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.997	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.997	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.997	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.997	0.000
Y47.4 Bromine compounds	0.002	0.997	0.000
Y47.3 Paraldehyde	0.002	0.997	0.000
Y47.2 Chloral derivatives	0.002	0.997	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.997	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.997	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.997	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.997	0.000
Y58.5 Diphtheria vaccine	0.002	0.997	0.000
Y58.4 Tetanus vaccine	0.002	0.997	0.000
Y58.3 Plague vaccine	0.002	0.997	0.000
Y58.2 Cholera vaccine	0.002	0.997	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.997	0.000
H16.4 Corneal neovascularisation	0.002	0.997	0.000
N73.8 Other specified female pelvic inflammatory diseases	0.002	0.997	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.997	0.000
J30.4 Allergic rhinitis, unspecified	0.000	0.997	0.003
N75.1 Abscess of Bartholin's gland	0.003	0.997	0.000
M24.5 Contracture of joint	0.000	0.997	0.002
D60 Acquired pure red cell aplasia [erythroblastopenia]	0.002	0.997	0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.002	0.997	0.000
H18.4 Corneal degeneration	0.002	0.998	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.002	0.998	0.000
Y50.9 Central nervous system stimulant, unspecified	0.002	0.998	0.000
Y50.8 Other central nervous system stimulants	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.998	0.000
Y50.1 Opioid receptor antagonists	0.002	0.998	0.000
Y50.0 Analeptics	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
M24.39 Pathological dislocation and subluxation of joint, not elsewhere classified (Site unspecified)	0.000	0.998	0.002
M24.38 Pathological dislocation and subluxation of joint, not elsewhere classified (Other)	0.000	0.998	0.002
M24.36 Pathological dislocation and subluxation of joint, not elsewhere classified (Lower leg)	0.000	0.998	0.002
M24.35 Pathological dislocation and subluxation of joint, not elsewhere classified (Pelvic region and thigh)	0.000	0.998	0.002
M24.34 Pathological dislocation and subluxation of joint, not elsewhere classified (Hand)	0.000	0.998	0.002
M24.33 Pathological dislocation and subluxation of joint, not elsewhere classified (Forearm)	0.000	0.998	0.002
M24.32 Pathological dislocation and subluxation of joint, not elsewhere classified (Upper arm)	0.000	0.998	0.002
M24.31 Pathological dislocation and subluxation of joint, not elsewhere classified (Shoulder region)	0.000	0.998	0.002
M24.30 Pathological dislocation and subluxation of joint, not elsewhere classified (Multiple sites)	0.000	0.998	0.002
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
M24.28 Disorder of ligament (Other)	0.000	0.998	0.002
Y46.4 Iminostilbenes	0.002	0.998	0.000
M24.67 Ankylosis of joint (Ankle and foot)	0.000	0.998	0.002
H15.9 Disorder of sclera, unspecified	0.002	0.998	0.000
H15.0 Scleritis	0.002	0.998	0.000
Y40.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.998	0.000
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.002	0.998	0.000
H57.9 Disorder of eye and adnexa, unspecified	0.000	0.998	0.002
K91.3 Postoperative intestinal obstruction	0.002	0.998	0.000
S91.0 Open wound of ankle	0.000	0.998	0.002
D80-D89 Certain disorders involving the immune mechanism	0.002	0.998	0.000
O43.1 Malformation of placenta	0.000	0.998	0.002
Y40.8 Other systemic antibiotics	0.002	0.998	0.000
N73.1 Chronic parametritis and pelvic cellulitis	0.002	0.998	0.000
R45.8 Other symptoms and signs involving emotional state	0.000	0.998	0.002
D86.1 Sarcoidosis of lymph nodes	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.002	0.998	0.000
Y56.8 Other topical agents	0.002	0.998	0.000
Y56.7 Dental drugs, topically applied	0.002	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
Y56.2 Local astringents and local detergents	0.002	0.998	0.000
Y56.1 Antipruritics	0.002	0.998	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.998	0.000
Y53.4 Other laxatives	0.002	0.998	0.000
M24.29 Disorder of ligament (Site unspecified)	0.000	0.998	0.002
M24.25 Disorder of ligament (Pelvic region and thigh)	0.000	0.998	0.002
M24.22 Disorder of ligament (Upper arm)	0.000	0.998	0.002
M24.20 Disorder of ligament (Multiple sites)	0.000	0.998	0.002
H16.9 Keratitis, unspecified	0.002	0.998	0.000
Y46.8 Antispasticity drugs	0.002	0.998	0.000
Y46.5 Valproic acid	0.002	0.998	0.000
Y46.3 Deoxybarbiturates	0.002	0.998	0.000
Y46.1 Oxazolidinediones	0.002	0.998	0.000
Y46.0 Succinimides	0.002	0.998	0.000
M24.21 Disorder of ligament (Shoulder region)	0.000	0.998	0.002
C85.1 B-cell lymphoma, unspecified	0.002	0.998	0.000
H16.3 Interstitial and deep keratitis	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
M24.23 Disorder of ligament (Forearm)	0.000	0.998	0.002
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
M25.62 Stiffness of joint, not elsewhere classified (Upper arm)	0.002	0.998	0.000
M24.8 Other specific joint derangements, not elsewhere classified	0.000	0.998	0.002
Y46.7 Anti-Parkinsonism drugs	0.002	0.998	0.000
Y40.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.002	0.998	0.000
S92.40 Fracture of great toe (closed)	0.000	0.998	0.002
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
Y83.3 Surgical operation with formation of external stoma	0.002	0.998	0.000
C69.9 Eye, unspecified	0.000	0.998	0.002
M24.54 Contracture of joint (Hand)	0.000	0.998	0.002
H15.8 Other disorders of sclera	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
N99 Postprocedural disorders of genito-urinary system, not elsewhere classified	0.002	0.998	0.000
N99.1 Postprocedural urethral stricture	0.002	0.998	0.000
R90.0 Intracranial space-occupying lesion	0.000	0.998	0.002
S91.7 Multiple open wounds of ankle and foot	0.000	0.998	0.002
S91.2 Open wound of toe(s) with damage to nail	0.000	0.998	0.002
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
H21 Other disorders of iris and ciliary body	0.002	0.998	0.000
Y57 Other and unspecified drugs and medicaments	0.002	0.998	0.000
M24.57 Contracture of joint (Ankle and foot)	0.000	0.998	0.002
D60.9 Acquired pure red cell aplasia, unspecified	0.002	0.998	0.000
D89.1 Cryoglobulinaemia	0.002	0.998	0.000
Y40.6 Rifamycins	0.002	0.998	0.000
Y40.4 Tetracyclines	0.002	0.998	0.000
Y40.2 Chloramphenicol group	0.002	0.998	0.000
M24.27 Disorder of ligament (Ankle and foot)	0.000	0.998	0.002
H21.8 Other specified disorders of iris and ciliary body	0.002	0.998	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.002
M24.37 Pathological dislocation and subluxation of joint, not elsewhere classified (Ankle and foot)	0.000	0.998	0.002
H16.8 Other keratitis	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
M24.26 Disorder of ligament (Lower leg)	0.000	0.998	0.002
M25.64 Stiffness of joint, not elsewhere classified (Hand)	0.002	0.998	0.000
S31.1 Open wound of abdominal wall	0.002	0.998	0.000
D83 Common variable immunodeficiency	0.002	0.998	0.000
D89.9 Disorder involving the immune mechanism, unspecified	0.002	0.998	0.000
H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
M24.59 Contracture of joint (Site unspecified)	0.000	0.998	0.002
M24.58 Contracture of joint (Other)	0.000	0.998	0.002
M24.53 Contracture of joint (Forearm)	0.000	0.998	0.002
M24.50 Contracture of joint (Multiple sites)	0.000	0.998	0.002
M25.63 Stiffness of joint, not elsewhere classified (Forearm)	0.002	0.998	0.000
D60.8 Other acquired pure red cell aplasias	0.002	0.998	0.000
D60.1 Transient acquired pure red cell aplasia	0.002	0.998	0.000
D60.0 Chronic acquired pure red cell aplasia	0.002	0.998	0.000
H19.8 Other disorders of sclera and cornea in diseases classified elsewhere	0.002	0.998	0.000
H19.0 Scleritis and episcleritis in diseases classified elsewhere	0.002	0.998	0.000
R45.2 Unhappiness	0.000	0.998	0.002
R79.9 Abnormal finding of blood chemistry, unspecified	0.002	0.998	0.000
D84 Other immunodeficiencies	0.002	0.998	0.000
H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere	0.002	0.998	0.000
R45.0 Nervousness	0.000	0.998	0.002
H19.1 Herpesviral keratitis and keratoconjunctivitis	0.002	0.998	0.000
M25.6 Stiffness of joint, not elsewhere classified	0.002	0.998	0.000
R90 Abnormal findings on diagnostic imaging of central nervous system	0.000	0.998	0.002
T18 Foreign body in alimentary tract	0.002	0.998	0.000
H20.0 Acute and subacute iridocyclitis	0.002	0.998	0.000
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
H16.1 Other superficial keratitis without conjunctivitis	0.002	0.998	0.000
H22.8 Other disorders of iris and ciliary body in diseases classified elsewhere	0.002	0.998	0.000
H22.0 Iridocyclitis in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
H57.8 Other specified disorders of eye and adnexa	0.000	0.998	0.002
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
D62 Acute posthaemorrhagic anaemia	0.002	0.998	0.000
D82 Immunodeficiency associated with other major defects	0.002	0.998	0.000
D81 Combined immunodeficiencies	0.002	0.998	0.000
H15.1 Episcleritis	0.002	0.998	0.000
Y57.5 X-ray contrast media	0.002	0.998	0.000
D80 Immunodeficiency with predominantly antibody defects	0.002	0.998	0.000
M24.84 Other specific joint derangements, not elsewhere classified (Hand)	0.000	0.998	0.002
Y40.5 Aminoglycosides	0.002	0.998	0.000
G47.0 Disorders of initiating and maintaining sleep [insomnias]	0.000	0.998	0.002
I80.1 Phlebitis and thrombophlebitis of femoral vein	0.002	0.998	0.000
N99.9 Postprocedural disorder of genito-urinary system, unspecified	0.002	0.998	0.000
F40 Phobic anxiety disorders	0.002	0.998	0.000
D11.0 Parotid gland	0.000	0.998	0.002
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.002	0.998	0.000
Y59.3 Immunoglobulin	0.002	0.998	0.000
R45 Symptoms and signs involving emotional state	0.000	0.998	0.002
M24.24 Disorder of ligament (Hand)	0.000	0.998	0.002
D83.9 Common variable immunodeficiency, unspecified	0.002	0.998	0.000
H21.0 Hyphaema	0.002	0.998	0.000
Q53.1 Undescended testicle, unilateral	0.000	0.998	0.002
M24.55 Contracture of joint (Pelvic region and thigh)	0.000	0.998	0.002
M24.89 Other specific joint derangements, not elsewhere classified (Site unspecified)	0.000	0.998	0.002
M24.88 Other specific joint derangements, not elsewhere classified (Other)	0.000	0.998	0.002
M24.82 Other specific joint derangements, not elsewhere classified (Upper arm)	0.000	0.998	0.002
M24.80 Other specific joint derangements, not elsewhere classified (Multiple sites)	0.000	0.998	0.002
M25.67 Stiffness of joint, not elsewhere classified (Ankle and foot)	0.002	0.998	0.000
M25.61 Stiffness of joint, not elsewhere classified (Shoulder region)	0.002	0.998	0.000
C34.1 Upper lobe, bronchus or lung	0.002	0.998	0.000
D89.3 Immune reconstitution syndrome	0.002	0.998	0.000
D89.0 Polyclonal hypergammaglobulinaemia	0.002	0.998	0.000
H22.1 Iridocyclitis in other diseases classified elsewhere	0.002	0.998	0.000
Y40.3 Macrolides	0.002	0.998	0.000
H21.9 Disorder of iris and ciliary body, unspecified	0.002	0.998	0.000
I77.1 Stricture of artery	0.000	0.998	0.002
X41.9 Unspecified place	0.002	0.998	0.000
H20 Iridocyclitis	0.002	0.998	0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.002	0.998	0.000
H16.2 Keratoconjunctivitis	0.002	0.998	0.000
M24.52 Contracture of joint (Upper arm)	0.000	0.998	0.002
M24.51 Contracture of joint (Shoulder region)	0.000	0.998	0.002
H21.4 Pupillary membranes	0.002	0.998	0.000
H21.3 Cyst of iris, ciliary body and anterior chamber	0.002	0.998	0.000
H60.9 Otitis externa, unspecified	0.002	0.998	0.000
M24.0 Loose body in joint	0.000	0.998	0.002
Y57.7 Vitamins, not elsewhere classified	0.002	0.998	0.000
Y57.4 Pharmaceutical excipients	0.002	0.998	0.000
Y57.3 Alcohol deterrents	0.002	0.998	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
Y57.1 Lipotropic drugs	0.002	0.998	0.000
Y57.0 Appetite depressants [anorectics]	0.002	0.998	0.000
D84.8 Other specified immunodeficiencies	0.002	0.998	0.000
N99.5 Malfunction of external stoma of urinary tract	0.002	0.998	0.000
M24.81 Other specific joint derangements, not elsewhere classified (Shoulder region)	0.000	0.998	0.002
M25.66 Stiffness of joint, not elsewhere classified (Lower leg)	0.002	0.998	0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.002	0.998	0.000
M50.0 Cervical disk disorder with myelopathy	0.000	0.998	0.002
R52.2 Other chronic pain	0.002	0.998	0.000
T18.3 Foreign body in small intestine	0.002	0.998	0.000
T91.1 Sequelae of fracture of spine	0.002	0.998	0.000
M24.83 Other specific joint derangements, not elsewhere classified (Forearm)	0.000	0.998	0.002
C69.3 Choroid	0.000	0.998	0.002
D83.8 Other common variable immunodeficiencies	0.002	0.998	0.000
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.002	0.998	0.000
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.002	0.998	0.000
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.002	0.998	0.000
N99.4 Postprocedural pelvic peritoneal adhesions	0.002	0.998	0.000
M25.65 Stiffness of joint, not elsewhere classified (Pelvic region and thigh)	0.002	0.998	0.000
D84.1 Defects in the complement system	0.002	0.998	0.000
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.002	0.998	0.000
T91 Sequelae of injuries of neck and trunk	0.002	0.998	0.000
M25.69 Stiffness of joint, not elsewhere classified (Site unspecified)	0.002	0.998	0.000
D84.9 Immunodeficiency, unspecified	0.002	0.998	0.000
M20.1 Hallux valgus (acquired)	0.000	0.998	0.002
N99.2 Postprocedural adhesions of vagina	0.002	0.998	0.000
Y57.6 Other diagnostic agents	0.002	0.998	0.000
Z45.1 Adjustment and management of infusion pump	0.000	0.998	0.002
M24.56 Contracture of joint (Lower leg)	0.000	0.998	0.001
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.002	0.998	0.000
O24.4 Diabetes mellitus arising in pregnancy	0.000	0.998	0.002
R45.6 Physical violence	0.000	0.998	0.002
S92.4 Fracture of great toe	0.000	0.998	0.002
T18.8 Foreign body in other and multiple parts of alimentary tract	0.002	0.998	0.000
T18.4 Foreign body in colon	0.002	0.998	0.000
T18.2 Foreign body in stomach	0.002	0.998	0.000
T18.0 Foreign body in mouth	0.002	0.998	0.000
C69 Malignant neoplasm of eye and adnexa	0.000	0.998	0.002
H57 Other disorders of eye and adnexa	0.000	0.998	0.002
H61 Other disorders of external ear	0.000	0.998	0.002
S72.30 Fracture of shaft of femur (closed)	0.000	0.998	0.002
F52.2 Failure of genital response	0.000	0.998	0.002
H58.8 Visual disturbances in diseases classified elsewhere	0.000	0.998	0.002
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.998	0.000
Q60-Q64 Congenital malformations of the urinary system	0.000	0.998	0.002
D81.9 Combined immunodeficiency, unspecified	0.001	0.998	0.000
D81.8 Other combined immunodeficiencies	0.001	0.998	0.000
D81.7 Major histocompatibility complex class II deficiency	0.001	0.998	0.000
D81.6 Major histocompatibility complex class I deficiency	0.001	0.998	0.000
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.001	0.998	0.000
D81.4 Nezelof's syndrome	0.001	0.998	0.000
D81.3 Adenosine deaminase [ADA] deficiency	0.001	0.998	0.000
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.001	0.998	0.000
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.001	0.998	0.000
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.001	0.998	0.000
D82.9 Immunodeficiency associated with major defect, unspecified	0.001	0.998	0.000
D82.8 Immunodeficiency associated with other specified major defects	0.001	0.998	0.000
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.001	0.998	0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.001	0.998	0.000
D82.2 Immunodeficiency with short-limbed stature	0.001	0.998	0.000
D82.1 Di George's syndrome	0.001	0.998	0.000
D82.0 Wiskott-Aldrich syndrome	0.001	0.998	0.000
H21.2 Degeneration of iris and ciliary body	0.001	0.998	0.000
O62.2 Other uterine inertia	0.002	0.998	0.000
M24.85 Other specific joint derangements, not elsewhere classified (Pelvic region and thigh)	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations